FORWARD FEATURES CALENDAR

Deals

Platinum Equity considers $2bn Club Car sale 

Private equity firm Platinum Equity has hired advisers from investment bank Goldman Sachs in exploring a sale of golf cart manufacturer Club Car that could value the company at more than $2bn, including debt, according to a report by Reuters citing unnamed sources.

Blackstone partners with Finnish S-Bank for European private credit fund 

Blackstone has partnered with Finland’s S-Bank to broaden access to its European private credit fund, with the latter creating a feeder fund that will invest its clients’ capital into the Blackstone European Private Credit Fund SICAV, according to a report by Alternative Credit Investor.

Gemspring Capital sells Insurvia to BharCap Partners 

US middle market private equity firm Gemspring Capital has completed the sale of insurance services holding company Insurvia to an affiliate of private investment firm BharCap Partners. Financial terms of the transaction have not been disclosed.

Ardian acquires data centre platform Verne in £450m deal

French private investment firm Ardian has completed the acquisition of the entire share capital of Verne, a data centre platform headquartered in the UK and diversified across Northern Europe, from investment trust Digital 9 Infrastructure, in a deal worth up to £450m.

KKR agrees €2.8bn Encavis acquisition

Global buyout firm KKR & Co has agreed a public takeover of German renewable energy company Encavis, valuing the company at €2.8bn, according to a report by Reuters. Elbe Bidco, an investment vehicle owned by KKR, has offered €17.50 per share.

Sagard acquires 40% stake in CLO manager HalseyPoint

Sagard, a global multi-strategy alternative investment fund with over $25bn in AUM across venture capital, private equity, private credit, real estate and royalties, is to acquire a 40% stake in US-based CLO manager HalseyPoint.

Andera Partners sells Amolyt Pharma to AstraZeneca in deal worth up to $1.05bn

Paris-based private equity firm Andera Partners has agreed to sell its portfolio company, Amolyt Pharma, a global biopharmaceutical company specialising in developing therapeutic peptides for rare endocrine and related diseases, to British-Swedish multinational pharma AstraZeneca, in a deal worth up to $1.05bn.

HarbourView secures $500m in debt financing from KKR

HarbourView Equity Partners, an alternative asset management firm focused on investments in the sports, media and entertainment space, has secured approximately $500m in a debt financing led by global investment firm KKR.

Events

12 November, 2026 – 5:00 pm

Directory Listings